Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection

ClinicalTrials.gov ID: NCT00736190

Public ClinicalTrials.gov record NCT00736190. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 1:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IV Study to Evaluate the Efficacy, Safety and Tolerability of Tenofovir DF in Asian-American Adults With Chronic Hepatitis B Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the antiviral activity and safety of tenofovir disoproxil fumarate (TDF) in Asian-American adults (self-reported Asian descent, living in the United States) with chronic hepatitis B infection. All participants will receive active treatment with TDF for 48 weeks.

Study identification

NCT ID
NCT00736190
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Gilead Sciences
Industry
Enrollment
90 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2008 (Type not available)
Primary completion
Jul 2010 (Actual)
Completion
Jul 2010 (Actual)
Last update posted
Dec 5, 2011

2008 – 2010

United States locations

U.S. sites
21
U.S. states
8
U.S. cities
20
Facility City State ZIP Site status
Not listed Fountain Valley California 92708 —
Not listed Hacienda Heights California 91745 —
Not listed Los Angeles California 90057 —
Not listed Monterey Park California 91754 —
Not listed Mountain View California 94040 —
Not listed Oakland California 94609 —
Not listed Palo Alto California 94304 —
Not listed San Jose California 95128 —
Not listed Hamden Connecticut 06518 —
Not listed Baltimore Maryland 21234 —
Not listed Laurel Maryland 20707 —
Not listed Silver Spring Maryland 20902 —
Not listed Englewood New Jersey 07631 —
Not listed Brooklyn New York 11219 —
Not listed Flushing New York 11355 —
Not listed New York New York 10013 —
Not listed New York New York 10038 —
Not listed Philadelphia Pennsylvania 19107 —
Not listed Fairfax Virginia 22030 —
Not listed Falls Church Virginia 22044 —
Not listed Bellevue Washington 98004 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00736190, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 5, 2011 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00736190 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →